Psychosocial Therapy Linked to Lower Suicide Risk in Previous Attempters

Psychosocial therapy significantly reduces suicide attempts and deaths among people who have previously attempted suicide, according to a new study.

Eczema Cases Rising Among U.S. Children

A growing number of children are being diagnosed with eczema - but it can usually be eased with topical treatments.

Are Some Docs Reluctant to See Newly Insured ACA Patients?

Millions of Americans bought health insurance coverage through the Affordable Care Act in the past year and physicians may be reluctant to accept these patients.

Hydroxyurea Therapy for Sickle Cell Anemia: Clinical Trial Halted

A clinical trial of hydroxyurea therapy for children with sickle cell anemia has been halted a year early because the results show it is a safe and effective way to manage the disease and reduce the risk of stroke.

Two Agents Show Promise for Hyperkalemia

For patients with hyperkalemia, sodium zirconium cyclosilicate (ZS-9) and patiromer show promise for reducing potassium levels, according to two new studies.

AAP: Pediatricians Should Be Involved in Oral Health Care

Pediatricians should perform oral health assessments and help maintain and restore oral health for the youngest children, according to a policy statement from the American Academy of Pediatrics (AAP).

No Mortality Benefit in MI Seen with Beta-Blockers in Era

In the reperfusion era, β-blocker use has no mortality benefit in myocardial infarction, and patients discharged with high heart rate after myocardial infarction have increased mortality risk during the first year.

Sugar-Sweetened Beverage, T2DM Link Confirmed in Meta-Analysis

New findings show that sugar-sweetened beverage intake is associated with increased risk of type 2 diabetes.

New Clinical Guidelines Issued for Paget's Disease

The Endocrine Society released a Clinical Practice Guideline for the diagnosis and treatment of Paget's disease of the bone.

Smartphone App to Monitor Opioid Addiction Tx: Clinical Trial Begins

AiCure announced the initiation of a major clinical trial assessing the company's advanced facial recognition and motion-sensing technology to monitor and intervene with patients on maintenance therapy for opioid addiction.